418 related articles for article (PubMed ID: 2994188)
1. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
De Leeuw PW; Van Oirschot JT
Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
Van Oirschot JT
Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
[TBL] [Abstract][Full Text] [Related]
3. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
van Oirschot JT; Gielkens AL
Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
Van Oirschot JT; De Leeuw PW
Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
van Oirschot JT
Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
[TBL] [Abstract][Full Text] [Related]
7. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
Pensaert MB; Vandeputte J; Andries K
Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
[TBL] [Abstract][Full Text] [Related]
8. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
Vannier P
Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
[TBL] [Abstract][Full Text] [Related]
10. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
[TBL] [Abstract][Full Text] [Related]
11. Parenteral and intranasal vaccination of fattening pigs against Aujeszky's disease (pseudorabies).
Pensaert M; Maes L
Zentralbl Veterinarmed B; 1984 Oct; 31(9):682-9. PubMed ID: 6097071
[No Abstract] [Full Text] [Related]
12. Intranasal vaccination of pigs against Aujeszky's disease. 1. Comparison of intranasal and parenteral vaccination with an attenuated vaccine in 12-week-old pigs from immunized dams.
de Leeuw PW; Wijsmuller JM; Zantinga JW; Tielen MJ
Vet Q; 1982 Apr; 4(2):49-56. PubMed ID: 6287698
[No Abstract] [Full Text] [Related]
13. [Trial of vaccination against Aujeszky's disease].
Motovski A; Veselinova A; Dobrev V
Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
Nauwynck HJ; Labarque GG; Pensaert MB
Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against Aujeszky's disease by different routes using live attenuated and inactivated virus vaccines in pigs with or without passive immunity.
Vannier P
Zentralbl Veterinarmed B; 1986 Nov; 33(9):704-12. PubMed ID: 3030027
[No Abstract] [Full Text] [Related]
16. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of maternally immune pigs with a live Aujeszky's disease vaccine by coarse spray and other routes.
Chong YC; Ng FK
Vet Microbiol; 1994 Mar; 39(1-2):117-24. PubMed ID: 8203117
[TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination on shedding of Aujeszky's disease virus in experimentally infected pigs and role of vaccination in herd health programmes.
Smíd B; Rodák L; Valícek L; Sabo A; Matis J
Acta Vet Hung; 1994; 42(2-3):391-6. PubMed ID: 7810436
[No Abstract] [Full Text] [Related]
19. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
20. Evaluation in swine of a subunit vaccine against pseudorabies.
Maes RK; Schutz JC
Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
